• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Immune-metabolic trajectories delineate subgroups in paediatric long COVID

tetano

Editor, Senior Moderator
Nat Commun


. 2026 May 4;17(1):4023.
doi: 10.1038/s41467-026-72224-y.
Immune-metabolic trajectories delineate subgroups in paediatric long COVID

Daniel Vilser[SUP] 1 2 [/SUP], Irina Han[SUP] 3 4 [/SUP], Katrin Vogel[SUP] 3 4 [/SUP], Pauline Jakobs[SUP] 3 [/SUP], Michael Lorenz[SUP] 5 [/SUP], Peter Huppke[SUP] 6 7 [/SUP], Lars Newman[SUP] 1 6 [/SUP], Michelle Paszkier[SUP] 3 [/SUP], Jens Kuhle[SUP] 8 [/SUP], Juliane Mohr[SUP] 4 9 [/SUP], Clara Aign[SUP] 3 [/SUP], Annegret Reinhold[SUP] 4 9 [/SUP], Dirk Reinhold[SUP] 4 9 [/SUP], Stefan Weinzierl[SUP] 10 [/SUP], Elisabeth Ullmann[SUP] 1 [/SUP], Hans Proquitté[SUP] 11 [/SUP], Monika C Brunner-Weinzierl[SUP] 12 13 [/SUP]


Affiliations
Abstract

Most children and adolescents recover rapidly from SARS-CoV-2 infection, yet a subset develops paediatric long COVID (LC). How immune ontogeny shapes LC biology and heterogeneity remains unclear. We deeply phenotype a two-visit cohort with severe LC (n = 74) and controls (n = 27) spanning up to 3.2 years post index infection. Symptom burden remains high and neurofilament light chain (NfL) percentiles inversely associate with functional status (Bell score; r = -0.3536, P = 0.0060). Cardiopulmonary assessment and serology are unremarkable. Conventional autoantibodies are not enriched, whereas anti-DFS70 supports subgrouping. Immune features are temporally structured; SARS-CoV-2-associated mediators decline within 1 year, while innate-weighted, Th2-skewed cytokines persist. Metabolomics (43 metabolites) recapitulate the identified subgroups and align with EBV serostatus, disease phase (<1 year versus years 1-3.2), and anti-DFS70 positivity. In EBV-naïve LC, higher haemoglobin concentration (MCHC) tracks worse function, whereas higher IL-12p40, thiamine and basophils track milder impairment (all P ≤ 0.0170). These data delineate immune-metabolic and haematological axes of paediatric LC heterogeneity and support biomarker-guided stratification


 
Back
Top Bottom